Japan has approved the use of the experimental anti-viral drug remdesivir, for the treatment of coronavirus patients with severe symptoms.

Researchers in the US released some good news last week about a possible treatment for coronavirus — evidence that the experimental drug may help patients recover more quickly from the infection.

The US Food and Drug Administration has authorized remdesivir for emergency use in patients with severe Covid-19.

The Japanese Ministry of Health and Welfare granted special approval of the drug, developed by the US’s Gilead Pharmaceutical, just three days after it applied for approval.